Role of endosomes and lysosomes in human disease

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 5, 2014, Pages

  Maxfield, Frederick R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; ANIMAL; ATHEROSCLEROSIS; ENDOCYTOSIS; ENDOSOME; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; ENDOCYTOSIS; ENDOSOMES; HUMANS; LIPOPROTEINS, LDL; LYSOSOMAL STORAGE DISEASES; LYSOSOMES;

EID: 84899728600     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016931     Document Type: Article

References (88)

1. Aisen P., Enns C, Wessling-Resnick M. 2001. Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33: 940-959.
2. Angelini C., Semplicini C. 2012. Enzyme replacement therapy for Pompe Disease. CurrNeurolNeurosci Rep 12: 70-75.
3. Bard F., Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, et al. 2000. Peripherally administered antibodies against amyloid bpeptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6: 916-919.
4. Blennow K., Zetterberg H, Fagan AM. 2012. Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med 2: a006221.
5. Boissonneault V., Filali M, Lessard M, Relton J, Wong G, Rivest S. 2009. Powerful beneficial effects of macrophage colony-stimulating factor on b-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132: 1078-1092.
6. Borden L. A, Einstein R, Gabel CA, Maxfield FR. 1990. Acidification-dependent dissociation of endocytosed insulin precedes that of endocytosed proteins bearing the mannose 6-phosphate recognition marker. J Biol Chem 265: 8497-8504.
7. Braulke T., Bonifacino JS. 2009. Sorting of lysosomal proteins. Biochim Biophys Acta 1793: 605-614.
8. Brookmeyer R., Johnson E, Ziegler-Graham K, Arrighi HM. 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191.
9. Brown M. S, Goldstein JL. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci 96: 11041-11048.
10. Burgos P. V, Mardones GA, Rojas AL, daSilva LL, Prabhu Y, Hurley J. H, Bonifacino JS. 2010. Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex. Dev Cell 18: 425-436.
11. Capetillo-Zarate E, Gracia L, Tampellini D, Gouras GK. 2012. Intraneuronal Ab accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease. Neurodegener Dis 10: 56-59.
12. Carstea E. DM, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J., et al. 1997. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277: 228-231.
13. Choy R. W, Cheng Z, Schekman R. 2012. Amyloid precursor protein (APP) traffics fromthe cell surface via endosomes for amyloid b (Ab) production in the trans-Golgi network. Proc Natl Acad Sci 109: E2077-2082.
14. Chung H., Brazil MI, Soe TT, Maxfield FR. 1999. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid b-peptide by microglial cells. J Biol Chem 274: 32301-32308.
15. Cohen J. C, Hobbs HH. 2013. Simple genetics for a complex disease. Science 340: 689-690.
16. Cossart P., Helenius A. 2014. Endocytosis of viruses and bacteria. Cold Spring Harb Perpsect Biol doi: 10.1101/ cshperspect.a016972.
17. Deffieu M. S, Pfeffer SR. 2011. Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc Natl Acad Sci 108: 18932-18936.
18. de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O'Meara A, Parini R, et al. 2011. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: Results of a European consensus procedure. Orphanet J Rare Dis 6: 55.
19. Devlin C., Pipalia NH, Liao X, Schuchman EH, Maxfield FR, Tabas I. 2010. Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect. Traffic 11: 601-615.
20. Di Fiore PP, von Zastrow M. 2014. Endocytosis, signaling, and beyond. Cold Spring Harb Perpsect Biol doi: 10.1101/ cshperspect.a016865.
21. Dunn K. W, Maxfield FR. 1992. Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes. J Cell Biol 117: 301-310.
22. Dunn K. W, McGraw TE, Maxfield FR. 1989. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J Cell Biol 109: 3303-3314.
23. Dunn K. W, Mayor S, Myers JN, Maxfield FR. 1994. Applications of ratio fluorescence microscopy in the study of cell physiology. FASEB J 8: 573-582.
24. Gelsthorpe M. E, Baumann N, Millard E, Gale SE, Langmade SJ, Schaffer JE, Ory DS. 2008. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. J Biol Chem 283: 8229-8236.
25. Geuze H. J, Slot JW, Strous GJ, Peppard J, von Figura K, Hasilik A., Schwartz AL. 1984. Intracellular receptor sorting during endocytosis: Comparative immunoelectron microscopy of multiple receptors in rat liver. Cell 37: 195-204.
26. Ghosh P., Dahms NM, Kornfeld S. 2003. Mannose 6-phosphate receptors: New twists in the tale. Nat Rev Mol Cell Biol 4: 202-212.
27. Goldstein J. L, Brown MS. 2009. The LDL receptor. Arterioscler Thromb Vasc Biol 29: 431-438.
28. Grosheva I., Haka AS, Qin C, Pierini LM, Maxfield FR. 2009. Aggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization. Arterioscler Thromb Vasc Biol 29: 1615-1621.
29. Gruenberg J., Maxfield FR. 1995. Membrane transport in the endocytic pathway. Curr Opin Cell Biol 7: 552-563.
30. Haka A. S, Grosheva I, Chiang E, Buxbaum AR, Baird BA, Pierini L. M, Maxfield FR. 2009. Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins. Mol Biol Cell 20: 4932-4940.
31. Haka A. S, Grosheva I, Singh RK, Maxfield FR. 2013. Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein. Arterioscler Thromb Vasc Biol 33: 1768-1778.
32. Hao M., Maxfield FR. 2000. Characterization of rapid membrane internalization and recycling. J Biol Chem 275: 15279-15286.
33. Hardy J., Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356.
34. Horton J. D, Cohen JC, Hobbs HH. 2009. PCSK9: A convertase that coordinates LDL catabolism. J Lipid Res 50: S172-S177.
35. Howes M. T, Mayor S, Parton RG. 2010. Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Curr Opin Cell Biol 22: 519-527.
36. Huse J. T, Pijak DS, Leslie GJ, Lee VM, Doms RW. 2000. Maturation and endosomal targeting of b-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease b-secretase. J Biol Chem 275: 33729-33737.
37. Hutt D. M, Herman D, Rodrigues AP, Noel S, Pilewski JM, Matteson J., Hoch B, KellnerW, Kelly JW, Schmidt A, et al. 2010. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol 6: 25-33.
38. Ishida Y., Nayak S, Mindell JA, Grabe M. 2013. A model of lysosomal pH regulation. J Gen Physiol 141: 705-720.
39. Jancic C., Savina A, Wasmeier C, Tolmachova T, El-Benna J, Dang P. M, Pascolo S, Gougerot-Pocidalo MA, Raposo G, Seabra M. C, et al. 2007. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 9: 367-378.
40. Kakavanos R., Turner CT, Hopwood JJ, Kakkis ED, Brooks DA. 2003. Immune tolerance after long-term enzymereplacement therapy among patients who have mucopolysaccharidosis I. Lancet 361: 1608-1613.
41. Koenigsknecht-Talboo J, Meyer-Luehmann M, Parsadanian M, Garcia-Alloza M, Finn MB, Hyman BT, Bacskai BJ, Holtzman D.M. 2008. Rapid microglial response around amyloid pathology after systemic anti-Ab antibody administration in PDAPP mice. J Neurosci 28: 14156-14164.
42. Kolter T., Sandhoff K. 2005. Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21: 81-103.
43. Kuter D. J, Mehta A, Hollak CE, Giraldo P, Hughes D, Belmatoug N, Brand M, Muller A, Schaaf B, Giorgino R, et al. 2013. Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study. Blood Cells Mol Dis 51: 116-124.
44. Kwon H. J, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. 2009. Structure of Nterminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137: 1213-1224.
45. Lachmann R.H. 2011. Enzyme replacement therapy for lysosomal storage diseases. Curr Opin Pediatr 23: 588-593.
46. Liou H. L, Dixit SS, Xu S, Tint GS, Stock AM, Lobel P. 2006. NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols. J Biol Chem 281: 36710-36723.
47. Lu J., Yang C, Chen M, Ye DY, Lonser RR, Brady RO, Zhuang Z. 2011. Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc Natl Acad Sci 108: 21200-21205.
48. Majumdar A., Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P., Maxfield FR. 2007. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol Biol Cell 18: 1490-1496.
49. Majumdar A., Chung H, Dolios G, Wang R, Asamoah N, Lobel P., Maxfield FR. 2008. Degradation of fibrillar forms of Alzheimer's amyloid b-peptide by macrophages. Neurobiol Aging 29: 707-715.
50. Majumdar A., Capetillo-Zarate E, Cruz D, Gouras GK, Maxfield FR. 2011. Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol Biol Cell 22: 1664-1676.
51. Maxfield F. R, Tabas I. 2005. Role of cholesterol and lipid organization in disease. Nature 438: 612-621.
52. Maxfield F. R, Yamashiro DJ. 1987. Endosome acidification and the pathways of receptor-mediated endocytosis. Adv Exp Med Biol 225: 189-198.
53. Mayor S., Pagano RE. 2007. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8: 603-612.
54. Mechtler T. P, Stary S, Metz TF, De Jesus VR, Greber-Platzer S, Pollak A, Herkner KR, Streubel B, Kasper DC. 2012. Neonatal screening for lysosomal storage disorders: Feasibility and incidence from a nationwide study in Austria. Lancet 379: 335-341.
55. Meikle P. J, Hopwood JJ, Clague AE, Carey WF. 1999. Prevalence of lysosomal storage disorders. JAMA 281: 249-254.
56. Mellman I., Yarden Y. 2013. Endocytosis and cancer. Cold Spring Harb Perpsect Biol 5: a016949.
57. Miller E. H, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne A. I, et al. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 31: 1947-1960.
58. Minino A.M. 2013. Death in the United States, 2011. NCHS Data Brief 115: 1-8.
59. Mistry P. K, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H, Helena Solano M, Spigelman Z, Villarrubia J., Watman NP, et al. 2011. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol 86: 110-115.
60. Moore K. J, Tabas I. 2011. Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
61. Mucke L., Selkoe DJ. 2012. Neurotoxicity of amyloid b-protein: Synaptic and network dysfunction. Cold Spring Harb Perspect Med 2: a006338.
62. Mukherjee S., Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol Rev 77: 759-803.
63. Paresce D. M, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid b-protein via a scavenger receptor. Neuron 17: 553-565.
64. Patterson M. C, Vecchio D, Prady H, Abel L, Wraith JE. 2007. Miglustat for treatment of Niemann-Pick C disease: A randomised controlled study. Lancet Neurol 6: 765-772.
65. Pipalia N. H, Maxfield FR. 2011. Investigating the therapeutic potential of HDAC inhibitors for the treatment of Niemann Pick type C1 disease. Mol Biol Cell 22: abstract #1642. http://niemannpick.nd.edu/assets/52702/all_ abstracts.pdf.
66. Pipalia N. H, Cosner CC, Huang A, Chatterjee A, Bourbon P, Farley N., Helquist P, WiestO, Maxfield FR. 2011. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. Proc Natl Acad Sci 108: 5620-5625.
67. Pisani A., Visciano B, Roux GD, Sabbatini M, Porto C, Parenti G, Imbriaco M. 2011. Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature. Mol Genet Metab 107: 267-275.
68. Rome L. H, Weissmann B, Neufeld EF. 1979. Direct demonstration of binding of a lysosomal enzyme, a-L-iduronidase, to receptors on cultured fibroblasts. Proc Natl Acad Sci 76: 2331-2334.
69. Rudenko G., Henry L, Henderson K, Ichtchenko K, Brown MS, Goldstein JL, Deisenhofer J. 2002. Structure of the LDL receptor extracellular domain at endosomal pH. Science 298: 2353-2358.
70. Schuchman E.H. 2009. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. Int J Clin Pharmacol Ther 47 (Suppl 1): S48-S57.
71. Selkoe D.J. 2012. Alzheimer's disease. Cold Spring Harb Perspect Biol 3: a004457.
72. Shah M., BaterinaOY Jr, TaupinV, Farquhar MG. 2013. ARH directs megalin to the endocytic recycling compartment to regulate its proteolysis and gene expression. J Cell Biol 202: 113-127.
73. Sondhi D., Johnson L, Purpura K, Monette S, Souweidane MM, Kaplitt MG, Kosofsky B, Yohay K, Ballon D, Dyke J, et al. 2012. Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther Methods 23: 324-335.
74. Steinberg B. E, Huynh KK, Brodovitch A, Jabs S, Stauber T, Jentsch T. J, Grinstein S. 2010. A cation counterflux supports lysosomal acidification. J Cell Biol 189: 1171-1186.
75. Suzuki Y. 2013. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease. Brain Dev 35: 515-523.
76. Thinakaran G., Koo EH. 2008. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283: 29615-29619.
77. Toei M., Saum R, Forgac M. 2010. Regulation and isoform function of the V-ATPases. Biochemistry 49: 4715-4723.
78. Tortorella L. L, Schapiro FB, Maxfield FR. 2007. Role of an acidic cluster/dileucine motif in cation-independent mannose 6-phosphate receptor traffic. Traffic 8: 402-413.
79. Trombetta E. S, Ebersold M, GarrettW, Pypaert M, Mellman I. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403.
80. Vanier M.T. 2010. Niemann-Pick disease type C. Orphanet J Rare Dis 5: 16.
81. Walkley S.U. 1998. Cellular pathology of lysosomal storage disorders. Brain Pathol 8: 175-193.
82. Wang M. L, Motamed M, Infante RE, Abi-Mosleh L, Kwon HJ, Brown MS, Goldstein JL. 2010. Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metab 12: 166-173.
83. Xu S., Benoff B, Liou HL, Lobel P, Stock AM. 2007. Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease. J Biol Chem 282: 23525-23531.
84. Yamashiro D. J, Maxfield FR. 1987. Kinetics of endosome acidification in mutant and wild-type Chinese hamster ovary cells. J Cell Biol 105: 2713-2721.
85. Yamashiro D. J, Tycko B, Fluss SR, Maxfield FR. 1984. Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37: 789-800.
86. Yong V. W, Rivest S. 2009. Taking advantage of the systemic immune system to cure brain diseases. Neuron 64: 55-60.
87. Young S. G, Zechner R. 2013. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev 27: 459-484.
88. Zhang W. Y, Gaynor PM, Kruth HS. 1997. Aggregated low density lipoprotein induces and enters surfaceconnected compartments of human monocyte-macrophages. Uptake occurs independently of the low density lipoprotein receptor. J Biol Chem 272: 31700-31706.